CareDx Inc
CDNA
NASDAQ
Biotechnology
$45.32
USD
-2.06 (-4.35%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.45B
Volume 708.6K
Revenue
$458.09M
TTM
+34.4%
YoY
Gross Margin
71%
TTM
+5.5%
YoY
Net Income
$111.01M
TTM
+90.9%
YoY
Operating Cash Flow
$93.66M
TTM
+428.5%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 86.7 | 100.1 | 108.4 | 117.7 | 131.9 |
YoY Growth | -6.1% | +20.7% | +25.2% | +39.0% | +52.2% |
Cost of Revenue | 28.7 | 30.7 | 35.5 | 33.6 | 35.0 |
Gross Profit | 58.0 | 69.4 | 72.9 | 84.1 | 97.0 |
Selling, General & Administrative | 52.0 | 52.9 | 59.6 | 60.9 | 74.3 |
Other Operating Expenses | 0.4 | 0.0 | 0.0 | 0.6 | 0.0 |
Total Operating Expenses | 69.1 | 69.6 | 78.9 | 82.9 | 96.7 |
Operating Income | -11.1 | -0.2 | -6.0 | 1.2 | 0.3 |
EBITDA | -7.0 | 3.6 | -2.2 | 5.7 | 3.1 |
Other Income / Expense | 0.1 | -0.1 | 0.3 | -0.3 | 112.5 |
Total Other Income / Expense | 2.4 | 1.9 | 2.3 | 1.6 | 114.3 |
Income Before Income Taxes | -8.7 | 1.7 | -3.8 | 2.8 | 114.5 |
Income Taxes | -0.1 | -0.0 | 0.3 | -0.0 | 3.9 |
Net Income | -8.6 | 1.7 | -4.1 | 2.8 | 110.6 |
Consolidated Net Income / Loss | -8.6 | 1.7 | -4.1 | 2.8 | 110.6 |
Net Income Attributable to Common Shareholders | -8.6 | 1.7 | -4.1 | 2.8 | 110.6 |
Basic EPS | -$0.16 | $0.03 | -$0.08 | $0.05 | $2.15 |
Diluted EPS | -$0.16 | $0.03 | -$0.08 | $0.05 | $2.07 |
Basic Shares Outstanding | 54.3M | 52.5M | 51.1M | 51.2M | 51.5M |
Diluted Shares Outstanding | 54.3M | 53.7M | 49.8M | 53.1M | 53.4M |